Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Irinotecan and 5-FU/LV with Radiation in Colorectal Cancer
NCT00004005Phase 2Completed
- Sponsor
- St. Jude Children's Research Hospital
- Start
- Sep 1998
- Primary completion
- Oct 2005
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of irinotecan in colorectal carcinoma (CRC), carcinoma of unknown primary (CUP), solid tumor, sponsored by St. Jude Children's Research Hospital. Started Sep 1998; status: completed.
02
Drugs
irinotecan
03
Conditions
colorectal carcinoma (CRC)carcinoma of unknown primary (CUP)solid tumor
Beyond the preview
Go deeper on NCT00004005.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00004005.